Comparison of the Persistence of Anti-TNF Agents and Ustekinumab in Patients with Crohn's Disease: A Study Based on the Korean National Database.

Published in: Journal of clinical medicine (2023)

Ustekinumab was superior in bio-naïve CD patients compared to anti-TNF inhibitors. However, the follow-up time was relatively short; further studies should continuously collect and analyse data.

Keyphrases

end stage renal disease
rheumatoid arthritis
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
electronic health record
emergency department
quality improvement
adverse drug